Changes in the epidemiology and management of bacterial infections in cirrhosis
Salvatore Piano, Marta Tonon, Paolo Angeli
Clin Mol Hepatol. 2021;27(3):437-445.   Published online 2021 Jan 28     DOI: https://doi.org/10.3350/cmh.2020.0329
Citations to this article as recorded by Crossref logo
Pre‐transplant multidrug‐resistant infections in liver transplant recipients‐epidemiology and impact on transplantation outcome
Gabriela T. Lemos, Debora R. B. Terrabuio, Nathalia N. Nunes, Alice T. W. Song, Isabel C. V. Oshiro, Luiz Augusto C. D'Albuquerque, Anna S. Levin, Edson Abdala, Maristela P. Freire
Clinical Transplantation.2024;[Epub]     CrossRef
Identifying hub genes of sepsis-associated and hepatic encephalopathies based on bioinformatic analysis—focus on the two common encephalopathies of septic cirrhotic patients in ICU
Juan Li, Dong Yang, Shengmei Ge, Lixia Liu, Yan Huo, Zhenjie Hu
BMC Medical Genomics.2024;[Epub]     CrossRef
Kidney pathology in liver cirrhosis
E. G. Malaeva
Health and Ecology Issues.2024; 20(4): 70.     CrossRef
Navigating the Labyrinth: Intensive Care Challenges for Patients with Acute-on-Chronic Liver Failure
Fuat H. Saner, Dimitri A. Raptis, Saad A. Alghamdi, Massimo M. Malagó, Dieter C. Broering, Dmitri Bezinover
Journal of Clinical Medicine.2024; 13(2): 506.     CrossRef
High‐dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study
Jun Sik Yoon, Ji Hoon Hong, Soo Young Park, Seung Up Kim, Hwi Young Kim, Ju Yeon Kim, Moon Haeng Hur, Min Kyung Park, Yun Bin Lee, Han Ah Lee, Gi‐Ae Kim, Dong Hyun Sinn, Sung Jae Park, Youn Jae Lee, Yoon Jun Kim, Jung‐Hwan Yoon, Jeong‐Hoon Lee
Alimentary Pharmacology & Therapeutics.2024;[Epub]     CrossRef
Incidence, risk factors and clinical outcomes of multidrug-resistant microorganism infections among patients admitted for decompensated cirrhosis: A prospective study
Helena Masnou, Ariadna Aguilar, Ignacio Iborra, Margarita Sala, Maria Torner, Ariadna Clos-Parals, Alba Ardèvol, Montserrat Giménez, Marta Fortuny, Maria Rosa Sarrias, Rosa M. Morillas, Eugeni Domènech
Gastroenterología y Hepatología.2023; 46(4): 288.     CrossRef
Impact of multidrug resistance on the management of bacterial infections in cirrhosis
Carlos Terra, Ângelo Zambam de Mattos, Marcelo Souza Chagas, Andre Torres, Denusa Wiltgen, Barbara Muniz Souza, Renata Mello Perez
World Journal of Clinical Cases.2023; 11(3): 534.     CrossRef
Old and New Precipitants in Hepatic Encephalopathy: A New Look at a Field in Continuous Evolution
Daniele Bellafante, Stefania Gioia, Jessica Faccioli, Oliviero Riggio, Lorenzo Ridola, Silvia Nardelli
Journal of Clinical Medicine.2023; 12(3): 1187.     CrossRef
Infection prevention and control programme and COVID-19 measures: Effects on hospital-acquired infections in patients with cirrhosis
Simone Di Cola, Jakub Gazda, Lucia Lapenna, Giancarlo Ceccarelli, Manuela Merli
JHEP Reports.2023; 5(5): 100703.     CrossRef
The Role of Microbiota in Liver Transplantation and Liver Transplantation-Related Biliary Complications
Ulrich Wirth, Tianxiao Jiang, Josefine Schardey, Katharina Kratz, Mingming Li, Malte Schirren, Florian Kühn, Alexandr Bazhin, Jens Werner, Markus Guba, Christian Schulz, Joachim Andrassy
International Journal of Molecular Sciences.2023; 24(5): 4841.     CrossRef
Challenges and recommendations when selecting empirical antibiotics in patients with cirrhosis
Melisa Dirchwolf, Gonzalo Gomez Perdiguero, Ingrid Mc Grech, Sebastian Marciano
World Journal of Hepatology.2023; 15(3): 377.     CrossRef
Clinical and microbiological characteristics of bacterial infections in patients with cirrhosis. A prospective cohort study from Argentina and Uruguay
Carolina Vazquez, María Nelly Gutierrez-Acevedo, Sabrina Barbero, Lorena del Carmen Notari, Marina Agozino, José Luis Fernandez, María Margarita Anders, Nadia Lorena Grigera, Florencia Antinucci, Orlando Nicolas Federico Orozco-Ganem, María Dolores Murga,
Annals of Hepatology.2023; 28(4): 101097.     CrossRef
Gut Microbiota and Infectious Complications in Advanced Chronic Liver Disease: Focus on Spontaneous Bacterial Peritonitis
Valeria Maccauro, Carlo Airola, Francesco Santopaolo, Antonio Gasbarrini, Francesca Romana Ponziani, Maurizio Pompili
Life.2023; 13(4): 991.     CrossRef
Bacterial Infections in Acute on Chronic Liver Failure
Simone Incicco, Paolo Angeli, Salvatore Piano
Clinics in Liver Disease.2023; 27(3): 703.     CrossRef
Real-world efficacy of antibiotic prophylaxis for upper gastrointestinal bleeding in cirrhotic patients in Japan
Masayuki Ueno, Takashi Fujiwara, Hironobu Tokumasu, Toshifumi Mano, Takahisa Kayahara, Hiroyuki Takabatake, Youichi Morimoto, Kazuhiro Matsueda, Toshio Fukuoka, Motowo Mizuno
Journal of Gastroenterology.2023; 58(8): 766.     CrossRef
Incidence, risk factors and clinical outcomes of multidrug-resistant microorganism infections among patients admitted for decompensated cirrhosis: A prospective study
Helena Masnou, Ariadna Aguilar, Ignacio Iborra, Margarita Sala, Maria Torner, Ariadna Clos-Parals, Alba Ardèvol, Montserrat Giménez, Marta Fortuny, Maria Rosa Sarrias, Rosa M. Morillas, Eugeni Domènech
Gastroenterología y Hepatología (English Edition).2023; 46(4): 288.     CrossRef
Management of sepsis in a cirrhotic patient admitted to the intensive care unit: A systematic literature review
Nkola Ndomba, Jonathan Soldera
World Journal of Hepatology.2023; 15(6): 850.     CrossRef
Antibiotic resistance in patients with liver cirrhosis: Prevalence and current approach to tackle
Valentina Liakina
World Journal of Clinical Cases.2023; 11(31): 7530.     CrossRef
Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in Germany
Wolfgang Maximilian Kremer, Simon Johannes Gairing, Leonard Kaps, Esmeralda Ismail, Vasiliki Kalampoka, Max Hilscher, Maurice Michel, Ekkehard Siegel, Jörn M. Schattenberg, Peter R. Galle, Martin F. Sprinzl, Marcus-Alexander Wörns, Michael Nagel, Christia
Annals of Hepatology.2022; 27(5): 100719.     CrossRef
Management of Multidrug-Resistant Infections in Cirrhosis
Charles E. Gallaher, Debbie L. Shawcross
Seminars in Liver Disease.2022; 42(02): 173.     CrossRef
Reappraisal of sepsis-3 and CLIF-SOFA as predictors of mortality in patients with cirrhosis and infection presenting to the emergency department: A multicenter study
Ji Hyun Kim, Baek Gyu Jun, Minjong Lee, Hye Ah Lee, Tae Suk Kim, Jeong Won Heo, Da Hye Moon, Seong Hee Kang, Ki Tae Suk, Moon Young Kim, Young Don Kim, Gab Jin Cheon, Soon Koo Baik, Dong Joon Kim, Dae Hee Choi
Clinical and Molecular Hepatology.2022; 28(3): 540.     CrossRef
Real‐world clinical features, health‐care utilization, and economic burden in decompensated cirrhosis patients: A national database
Hankil Lee, Beom Kyung Kim
Journal of Gastroenterology and Hepatology.2022; 37(11): 2154.     CrossRef
Early Diagnosis and Prevention of Infections in Cirrhosis
Anand V. Kulkarni, Madhumita Premkumar, Juan P. Arab, Karan Kumar, Mithun Sharma, Nageshwar D. Reddy, Nagaraja R. Padaki, Rajender K. Reddy
Seminars in Liver Disease.2022; 42(03): 293.     CrossRef
Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis
Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim, Joo Won Baik, Sun Young Yim, Young-Sun Lee, Yeon Seok Seo, Ji Hoon Kim, Jong Eun Yeon, Kwan Soo Byun
Clinical and Molecular Hepatology.2022; 28(4): 876.     CrossRef
New Evidence of Oral Branched-Chain Amino Acid Supplementation on the Prognosis of Patients With Advanced Liver Disease
Hankil Lee, Jeong-Ju Yoo, Sang Hoon Ahn, Beom Kyung Kim
Clinical and Translational Gastroenterology.2022; 13(12): e00542.     CrossRef
Antibiotics and Liver Cirrhosis: What the Physicians Need to Know
Caterina Zoratti, Rita Moretti, Lisa Rebuzzi, Irma Valeria Albergati, Antonietta Di Somma, Giuliana Decorti, Stefano Di Bella, Lory Saveria Crocè, Mauro Giuffrè
Antibiotics.2021; 11(1): 31.     CrossRef
Bacterial Infections in Cirrhosis
Marta Tonon, Paolo Angeli, Salvatore Piano
Infectious Microbes and Diseases.2021; 3(3): 117.     CrossRef